DARPA

Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label

Retrieved on: 
Monday, March 11, 2024

This significant advancement supports the Company’s submission for an additional EPA label.

Key Points: 
  • This significant advancement supports the Company’s submission for an additional EPA label.
  • Foot-and-mouth disease (FMD) represents a critical global threat, being an extremely contagious disease affecting a wide range of cloven-hoofed animals including cows, pigs, sheep, goats, and deer.
  • TOMI’s recent study has proven SteraMist iHP technology to eliminate infectious FMDV from both porous (concrete) and non-porous (stainless steel) surfaces in the presence of organic soil load.
  • Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.

TOMI Expands SteraMist iHP Corporate Service Contracts and Clients

Retrieved on: 
Thursday, March 7, 2024

FREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced an expansion in its SteraMist iHP Corporate Service contracts, reaffirming its position as a leading provider of decontamination services to corporate clients in the life sciences industry.

Key Points: 
  • FREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced an expansion in its SteraMist iHP Corporate Service contracts, reaffirming its position as a leading provider of decontamination services to corporate clients in the life sciences industry.
  • SteraMist iHP technology is becoming the standard decontamination technology in the life sciences sector and academic institutions with a broad spectrum of clients equipped with mobile systems, custom integrations, and service contracts.
  • In a notable development, Rising Pharmaceuticals has entered into an ongoing annual contract with TOMI’s SteraMist iHP Corporate Service following the acquisition of a building previously serviced by the team.
  • SteraMist iHP Corporate Service managed to decontaminate our entire facility quickly without causing harm to the infrastructure or our sensitive equipment.

TOMI Environmental Announces Additional iHP Custom Engineered System Installation Contracted for California

Retrieved on: 
Thursday, February 29, 2024

FREDERICK, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the signing of a new contract for a SteraMist iHP Custom Engineered System (CES) installation with a California-based life sciences company.

Key Points: 
  • FREDERICK, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the signing of a new contract for a SteraMist iHP Custom Engineered System (CES) installation with a California-based life sciences company.
  • The contracted iHP Custom Engineered System (CES) is valued at approximately $600,000.
  • Following a presentation by Dr. Halden Shane, CEO of TOMI, at an ISPE event hosted by Avid Bioservices, the contractors recognized the benefits of the automated iHP Custom Engineered System showcased in Avid's new facility and brought SteraMist iHP to the customer as an option.
  • Shane, COO of TOMI states, “We’re pleased to announce this new CES contract and look forward to continuing our growth momentum.

Circuitry.ai welcomes Dr. Lorien Pratt as Decision Intelligence Advisor

Retrieved on: 
Tuesday, February 20, 2024

"We are delighted to welcome Dr. Lorien Pratt as advisor to Circuitry.ai.

Key Points: 
  • "We are delighted to welcome Dr. Lorien Pratt as advisor to Circuitry.ai.
  • "As the inventor of decision intelligence, Dr. Pratt is unmatched in this space.
  • Dr. Pratt’s most recent DI book is "The Decision Intelligence Handbook: How Decision Intelligence connects Data, Actions, and Outcomes for a Better World."
  • "I am thrilled to be joining the Circuitry.ai leadership team as a Decision Intelligence advisor," said Dr. Lorien Pratt, "Circuitry.ai solutions are particularly important because they bring integrated, organization-wide evidence-based and data-driven decision making and AI into the enterprise.

VENUS AEROSPACE ROTATING DETONATION ROCKET ENGINE ACHIEVES LONG-DURATION RUN

Retrieved on: 
Thursday, March 7, 2024

HOUSTON, March 7, 2024 /PRNewswire/ -- Venus Aerospace, a company focused on making hypersonic flight a reality for commercial and defense purposes, has achieved the first long-duration engine test of their Rotating Detonation Rocket Engine (RDRE) in partnership with DARPA (Defense Advanced Research Projects Agency).

Key Points: 
  • HOUSTON, March 7, 2024 /PRNewswire/ -- Venus Aerospace, a company focused on making hypersonic flight a reality for commercial and defense purposes, has achieved the first long-duration engine test of their Rotating Detonation Rocket Engine (RDRE) in partnership with DARPA (Defense Advanced Research Projects Agency).
  • "As we continue to push towards our ultimate mission of high-speed global flight, this is an important technical milestone for having a flight-ready engine," said Andrew Duggleby, CTO and co-founder of Venus Aerospace.
  • Achieving the first hot-fire, long-duration engine test of Venus' RDRE is a significant feat, as it previously had only undergone short-duration tests, which run un-cooled hardware for quick and inexpensive test iterations.
  • We're building something special here at Venus, in large part because we have the right people and the right partners," said Sassie Duggleby, CEO and co-founder of Venus Aerospace.

Umbra Unveils Bistatic SAR Data from its Tandem Pair of Satellites

Retrieved on: 
Thursday, March 7, 2024

WASHINGTON, March 7, 2024 /PRNewswire/ -- Umbra, a vertically integrated space technology company, proudly announces the forthcoming release of imagery from its tandem pair of Synthetic Aperture Radar (SAR) satellites.

Key Points: 
  • WASHINGTON, March 7, 2024 /PRNewswire/ -- Umbra, a vertically integrated space technology company, proudly announces the forthcoming release of imagery from its tandem pair of Synthetic Aperture Radar (SAR) satellites.
  • Umbra is set to provide customers with bistatic SAR data later in 2024.
  • Umbra, a SAR satellite provider, is set to provide customers with bistatic data in 2024.
  • Umbra's high-performance SAR satellites deliver the highest quality SAR data at unprecedented volumes and area density, enabling the US.

EnCharge AI Partners with Princeton University on Groundbreaking AI Chip Technology Supported By U.S. Department of Defense (DoD)

Retrieved on: 
Wednesday, March 6, 2024

SANTA CLARA, Calif., March 6, 2024 /PRNewswire/ -- Today, EnCharge AI, the company commercializing next-generation AI accelerators, announced a partnership with Princeton University, supported by the U.S. Defense Advanced Research Projects Agency (DARPA) towards developing advanced processors capable of running AI models more efficiently than previously thought possible.

Key Points: 
  • As part of OPTIMA, DARPA has awarded an $18.6 million grant to a multi-year project proposed by Princeton University and EnCharge AI.
  • The rapid developments in AI have created skyrocketing processing requirements, currently addressed by massive server farms with high cost and power requirements.
  • Key to this Princeton University-EnCharge AI project is Dr. Naveen Verma, Professor of Electrical and Computer Engineering at Princeton and co-founder and CEO of EnCharge AI.
  • EnCharge AI CTO Dr. Kailash Gopalakrishnan noted that constraints posed by current AI processing technologies motivated EnCharge AI to participate in OPTIMA.

EverGlade Funding Alert - $300 Million Funding Opportunity Announced for CHIPS National Advanced Packaging Manufacturing Program (NAPMP)

Retrieved on: 
Monday, March 4, 2024

HOUSTON, March 4, 2024 /PRNewswire/ -- The U.S. government, through CHIPS for America, has announced a groundbreaking funding opportunity aimed at bolstering domestic research and development (R&D) in advanced semiconductor packaging materials and substrates. The initiative, part of the National Advanced Packaging Manufacturing Program (NAPMP), is set to inject approximately $300 million into innovations spanning semiconductor-based materials to glass and organics. This funding opportunity marks a significant step in the U.S.'s commitment to maintaining and advancing its leadership in the global semiconductor industry.

Key Points: 
  • The initiative, part of the National Advanced Packaging Manufacturing Program (NAPMP), is set to inject approximately $300 million into innovations spanning semiconductor-based materials to glass and organics.
  • This funding opportunity marks a significant step in the U.S.'s commitment to maintaining and advancing its leadership in the global semiconductor industry.
  • "This funding opportunity represents a pivotal moment for the U.S. semiconductor industry.
  • If your company has considered applying for CHIPS funding, your federal funding journey starts here.

DCS Corporation Names Jim Belcher Vice President of Ground Vehicle Systems Division

Retrieved on: 
Thursday, February 29, 2024

ALEXANDRIA, Va., Feb. 29, 2024 /PRNewswire/ -- DCS Corporation is pleased to announce the appointment of Jim Belcher as its new Vice President of Ground Vehicle Systems.

Key Points: 
  • ALEXANDRIA, Va., Feb. 29, 2024 /PRNewswire/ -- DCS Corporation is pleased to announce the appointment of Jim Belcher as its new Vice President of Ground Vehicle Systems.
  • Following the acquisition of IST by DCS, he managed the Special Programs Branch focusing on systems engineering with advanced materials and electronics to develop active thermal control, e-textiles, tethered drone power systems, and ground vehicle armor systems.
  • Since 2018, Jim has led DCS's Systems Engineering Department, providing systems and electrical engineering support to the Ground Vehicle Systems Center (GVSC) at the Detroit Arsenal.
  • In this position, Jim managed significant growth in areas of Vetronics, high-voltage power systems, production support, embedded robotic systems and safety systems architecture.

Every Cure to Receive $48.3M from ARPA-H to Develop AI-Driven Platform to Revolutionize Future of Drug Development and Repurposing

Retrieved on: 
Wednesday, February 28, 2024

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- Every Cure, a nonprofit on a mission to save lives by repurposing existing medicines, announced today significant funding from the Advanced Research Projects Agency for Health (ARPA-H). The three-year, $48.3 million contract was unveiled at the White House this evening and represents a substantial federal investment in drug repurposing. It will accelerate Every Cure's mission to unlock the full potential of existing drugs to treat more diseases through the development of an AI-powered platform, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX).

Key Points: 
  • The three-year, $48.3 million contract was unveiled at the White House this evening and represents a substantial federal investment in drug repurposing.
  • "I'm alive and in remission from my rare disease thanks to a repurposed drug that I discovered.
  • "Through Every Cure, we are working tirelessly to unlock the full potential of FDA-approved drugs to treat many more diseases.
  • The ARPA-H funding will enable Every Cure to:
    Develop an open-source drug repurposing database.